Trial Profile
Efficacy of 6-monthly injections of Denosumab on the Bone Mineral Density (BMD) in subjects with Postmenopausal Osteoporosis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 May 2016
Price :
$35
*
At a glance
- Drugs Denosumab (Primary) ; Calcium carbonate; Vitamin D
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- 11 May 2016 New trial record
- 17 Apr 2016 Results presented at the 2016 World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases